Tapewire

Nasdaq · USD

KRMD

KORU Medical Systems, Inc.

Export transactions ↓
Tapewire entity
6517
SEC CIK
0000704440
Parsed reports
474

Last 12 months

Inside the activity.

9 purchase rows · 0 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202600
Mar 202600
Apr 202600
May 202660
Jun 202620
Jul 202600
Aug 202600
Sep 202610
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
September 29, 2016 Filed Oct 3, 2016 20:34 UTC GrantCommon Stock 8,929 $0.00 $0.00
Disclosure

SEC source: 0001161697-16-001097 · form_4.xml · nonDerivative · entry 1

Anderson David W · CIK 0001304554 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,929

Read SEC document
September 29, 2016 Filed Oct 3, 2016 20:33 UTC GrantCommon Stock 8,929 $0.00 $0.00
Disclosure

SEC source: 0001161697-16-001095 · form_4.xml · nonDerivative · entry 1

Sealfon Brad Alexander · CIK 0001604872 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 93,929

Read SEC document
September 29, 2016 Filed Oct 3, 2016 20:27 UTC GrantCommon Stock 8,929 $0.00 $0.00
Disclosure

SEC source: 0001161697-16-001093 · form_4.xml · nonDerivative · entry 1

Radin Arthur J · CIK 0001632747 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 194,495

Read SEC document
September 29, 2016 Filed Oct 3, 2016 20:26 UTC GrantCommon Stock 8,929 $0.00 $0.00
Disclosure

SEC source: 0001161697-16-001092 · form_4.xml · nonDerivative · entry 1

Radin Arthur J · CIK 0001632747 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 194,495

Read SEC document
September 14, 2016 Filed Oct 3, 2016 20:41 UTC
Manko Joseph M. Jr.Director · 10% owner
GrantCommon Stock 1,746 $0.00 $0.00
Disclosure

SEC source: 0001161697-16-001103 · form_4.xml · nonDerivative · entry 1

Manko Joseph M. Jr. · CIK 0001664091 · Director · 10% owner

Horton Capital Management, LLC · CIK 0001575444 · 10% owner

Horton Capital Partners, LLC · CIK 0001575443 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · By Horton Capital Management, LLC

Disclosed balance after: 5,075,829

F1 · shares: See Exhibit 99.1 to this Form 4 for explanation of note (1).

F3 · ownership.nature: See Exhibit 99.1 to this Form 4 for explanation of note (3).

Read SEC document
September 06, 2016 Filed Sep 16, 2016 20:08 UTC GrantOptions to Purchase Common Stock · Derivative 500,000 $0.00 Strike: $0.38 $0.00
Disclosure

SEC source: 0001161697-16-001081 · form_4.xml · derivative · entry 1

Fisher Karen · CIK 0001406771 · CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 500,000

Underlying: Common Stock · 500,000 shares

Expires 2020-11-04

F1 · date: The Company's Board of Directors awarded these options on November 4, 2015, subject to shareholder approval of the Company's 2015 Stock Option Plan, as amended, which approval was obtained on September 6, 2016. The options vest on November 4, 2016, subject to acceleration upon a change of control of the Company, provided Ms. Fisher is employed with the Company on such date.

F1 · derivative.exercise_date: The Company's Board of Directors awarded these options on November 4, 2015, subject to shareholder approval of the Company's 2015 Stock Option Plan, as amended, which approval was obtained on September 6, 2016. The options vest on November 4, 2016, subject to acceleration upon a change of control of the Company, provided Ms. Fisher is employed with the Company on such date.

Read SEC document
September 01, 2016 Filed May 23, 2017 20:08 UTC Amendment
Manko Joseph M. Jr.Director · 10% owner
GrantCommon Stock 7,102 $0.00 $0.00
Disclosure

SEC source: 0001161697-17-000259 · form_4.xml · nonDerivative · entry 2

Manko Joseph M. Jr. · CIK 0001664091 · Director · 10% owner

Horton Capital Management, LLC · CIK 0001575444 · 10% owner

Horton Capital Partners, LLC · CIK 0001575443 · 10% owner

Horton Capital Partners Fund, L.P. · CIK 0001567994 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · By Horton Capital Partners Fund, LP

Disclosed balance after: 4,207,416

F4 · shares: See Exhibit 99.1 to this Form 4 for explanation of note (4).

F1 · ownership.nature: See Exhibit 99.1 to this Form 4 for explanation of note (1).

F3 · ownership.nature: See Exhibit 99.1 to this Form 4 for explanation of note (3).

Read SEC document
June 01, 2016 Filed May 23, 2017 20:08 UTC Amendment
Manko Joseph M. Jr.Director · 10% owner
GrantCommon Stock 1,746 $0.00 $0.00
Disclosure

SEC source: 0001161697-17-000259 · form_4.xml · nonDerivative · entry 1

Manko Joseph M. Jr. · CIK 0001664091 · Director · 10% owner

Horton Capital Management, LLC · CIK 0001575444 · 10% owner

Horton Capital Partners, LLC · CIK 0001575443 · 10% owner

Horton Capital Partners Fund, L.P. · CIK 0001567994 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · By Horton Capital Partners Fund, LP

Disclosed balance after: 3,990,001

F2 · shares: See Exhibit 99.1 to this Form 4 for explanation of note (2).

F1 · ownership.nature: See Exhibit 99.1 to this Form 4 for explanation of note (1).

F3 · ownership.nature: See Exhibit 99.1 to this Form 4 for explanation of note (3).

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.